What question did this study set out to answer?

The aim is to define the epigenetic profiles differentiating malignant pleural mesothelioma (MPM) from lung adenocarcinoma.

November 4, 2009Cancer Research

Epigenetic Profiles Distinguish Malignant Pleural Mesothelioma from Lung Adenocarcinoma

View Full Paper

Ask AI

Bookmark

The aim is to define the epigenetic profiles differentiating malignant pleural mesothelioma (MPM) from lung adenocarcinoma.
Performed high-throughput methylation analysis on 20 MPMs and 20 lung adenocarcinomas
Analyzed 50 MPMs and 56 adenocarcinomas using quantitative methylation-specific PCR
Assessed H3K27me3 targets in MPM cells via chromatin immunoprecipitation arrays.
Average of 387 genes (6.3%) were hypermethylated in MPM compared to 544 genes (8.8%) in adenocarcinoma
Three genes (TMEM30B, KAZALD1, MAPK13) were specifically hypermethylated in MPM, indicating potential diagnostic markers
A subset of MPM cases (20%) showed low DNA methylation levels with longer survival, implying a role in disease progression.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Randomized trial demonstrates distinct epigenetic profiles in malignant pleural mesothelioma versus lung adenocarcinoma, suggesting diagnostic potential.

Cite This Study

Gotô et al. (2009) studied this question.

synapsesocial.com/papers/6a70b9d9e71d69abee08cdcc https://doi.org/10.1158/0008-5472.can-09-1595

View Full Paper

Ask AI

Bookmark

Implication

Randomized trial demonstrates distinct epigenetic profiles in malignant pleural mesothelioma versus lung adenocarcinoma, suggesting diagnostic potential.

Epigenetic Profiles Distinguish Malignant Pleural Mesothelioma from Lung Adenocarcinoma

Key Points

Discussion

Implication

Cite This Study

Epigenetic Profiles Distinguish Malignant Pleural Mesothelioma from Lung Adenocarcinoma

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider